Late specialist access reduces opportunities for preemptive transplant.
Patient-initiated pathways miss eligible candidates and slow care.
Socioeconomic and racial disparities limit fair access to waitlisting
Fragmented, multi-step workflows delay decisions and treatment.

Auto-screen CKD patients (age, GFR, BMI); exclude malignancy, cirrhosis, major cardiac/pulmonary disease.

Generate and prioritize referrals for transplant center review.

Validate coverage against transplant center contracts.

Monthly follow-ups to complete evaluation checklists; notify centers upon completion.

Mark candidates as waitlisted; send fax and electronic notifications.

Enroll in RPM + MTM for adherence, adverse event detection, and outcomes.
Auto-screen CKD patients (age, GFR, BMI); exclude malignancy, cirrhosis, major cardiac/pulmonary disease.
Generate and prioritize referrals for transplant center review.
Validate coverage against transplant center contracts.
Monthly follow-ups to complete evaluation checklists; notify centers upon completion.
Mark candidates as waitlisted; fax and electronic notifications.
Enroll in RPM + MTM for adherence, adverse event detection, and outcomes.

Identify eligible CKD patients early to enable preem-ptive transplant and reduce dialysis time

Reduce manual admin and eliminate dependence on patient self-referrals.

Prevent delays by confirming eligibility before evaluation

Dynamic status tracking, admissions/transfusions updates, and coordination.

Pharmacist-led optimization of immunosuppressive therapy.





Track vitals (BP, HR, creatinine), generate real-time alerts for potential rejection or infection, and enable early intervention.

Pharmacist-led virtual consultations to optimize immunosuppressant, manage interactions, and improve adherence.